Publication: Efficacy of Pentoxifylline and Tadalafil in Rat Model of Ischemic ColITIS
| dc.contributor.authors | Reyhan, Enver; Irkorucu, Oktay; Surmelioglu, Ali; Ozkara, Selvinaz; Deger, Kamuran Cumhur; Aziret, Mehmet; Erdem, Hasan; Cetinkunar, Suleyman; Demirturk, Pelin; Sehirli, Ahmet Ozer | |
| dc.date.accessioned | 2022-03-13T12:46:38Z | |
| dc.date.accessioned | 2026-01-10T18:49:02Z | |
| dc.date.available | 2022-03-13T12:46:38Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Objective: The aim of this study is to investigate the efficacy of tadalafil against pentoxifylline in rat model of ischemic colitis (IC). Material-Methods: Thirty-twoWistar albino rats were subjected to laparotomy and left colon devascularization to create an IC model and then randomly placed into four groups. Group-1 (sham group) was administered 0.9% NaCl following laparotomy, group 2 (control group) was administered 0.9% NaCl following induced IC, group 3 was given pentoxifylline (n = 8), and group 4 was given tadalafil. On the third day; macroscopic findings, Gomella's ischemic area and Wallace scoring, histopathological analysis, and Chiu scoring were performed, and malondialdehyde (MDA) measurement in ischemic colon tissue was carried out through chemical analysis. Results: Significant differences were observed in acidic fluid, bowel dilatation, and serosal change (p < .05). The ischemic area measured 63.3 mm(2) in the control group, 2.8 mm(2) in the pentoxifylline group (p = .0001), and 2.4 mm(2) (p = .0001) in the tadalafil group. A significant difference was seen between the sham group and the control and pentoxifylline groups (p < .01), in terms of Wallace score and Chiu classification. Similarly, a significant difference was determined between the control group and pentoxifylline and tadalafil groups (p <.01), but no significant difference was established between the pentoxifylline group and tadalafil group (p = .33). MDA measurement was found on an average to be 63.7 in the control group, 22.7 in group 3 and 22.8 in group 4 (p = 001). Conclusion: Although tadalafil is superior to pentoxifylline, both drugs are considered to have positive effects. | |
| dc.identifier.doi | 10.3109/08941939.2014.971204 | |
| dc.identifier.eissn | 1521-0553 | |
| dc.identifier.issn | 0894-1939 | |
| dc.identifier.pubmed | 25361018 | |
| dc.identifier.uri | https://hdl.handle.net/11424/237955 | |
| dc.identifier.wos | WOS:000344484200005 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS INC | |
| dc.relation.ispartof | JOURNAL OF INVESTIGATIVE SURGERY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | ischemic colitis | |
| dc.subject | rat | |
| dc.subject | pentoxifylline | |
| dc.subject | phosphodiesterase-5 | |
| dc.subject | tadalafil | |
| dc.subject | malondialdehyde | |
| dc.subject | ERECTILE DYSFUNCTION | |
| dc.subject | REPERFUSION INJURY | |
| dc.subject | SMALL-INTESTINE | |
| dc.subject | RISK-FACTORS | |
| dc.subject | ISCHEMIA/REPERFUSION | |
| dc.subject | SILDENAFIL | |
| dc.subject | DISEASE | |
| dc.title | Efficacy of Pentoxifylline and Tadalafil in Rat Model of Ischemic ColITIS | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 353 | |
| oaire.citation.issue | 6 | |
| oaire.citation.startPage | 349 | |
| oaire.citation.title | JOURNAL OF INVESTIGATIVE SURGERY | |
| oaire.citation.volume | 27 |
